Methazolamide
12 NDCs across 6 manufacturers|12 Generic,0 Brand
Methazolamide is used to treat angle-closure glaucoma and open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 30, 1993. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $10 million on Methazolamide across 43,000 claims for 11,000 beneficiaries.
Methazolamide is available as 12 NDCs from 6 manufacturers (12 generic, 0 brand), with NADAC prices from $0.63 to $1.51 per EA — the most expensive product costs about 2.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
12G / 0B
Manufacturers
6
competing in market
Price Spread
$0.63 – $1.51
per EA
7d Activity
avg -3.8% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Oceanside Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing METHAZOLAMIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
METHAZOLAMIDE 50 MG TABLET | $1.5082 per EA | — |
METHAZOLAMIDE 50 MG TABLET | $1.5075 per EA | — |
METHAZOLAMIDE 50 MG TABLET | $1.4684 per EA | -2.59% |
METHAZOLAMIDE 50 MG TABLET | $1.4684 per EA | -2.59% |
METHAZOLAMIDE 50 MG TABLET | $1.4684 per EA | -2.59% |
METHAZOLAMIDE 50 MG TABLET | $1.4684 per EA | -2.59% |
METHAZOLAMIDE 25 MG TABLET | $0.9515 per EA | — |
METHAZOLAMIDE 25 MG TABLET | $0.6275 per EA | -4.80% |
METHAZOLAMIDE 25 MG TABLET | $0.6275 per EA | -4.80% |
METHAZOLAMIDE 25 MG TABLET | $0.6275 per EA | -4.80% |
METHAZOLAMIDE 25 MG TABLET | $0.6275 per EA | -4.80% |
METHAZOLAMIDE 25 MG TABLET | $0.6275 per EA | -4.80% |
Frequently Asked Questions
What is Methazolamide used to treat?
Methazolamide is used to treat angle-closure glaucoma and open-angle glaucoma, per the National Library of Medicine's MED-RT classification.
When did Methazolamide become available as a generic?
FDA approved the first generic Methazolamide (ANDA) on Jun 30, 1993. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Methazolamide?
In 2024, Medicare Part D spent $10 million on Methazolamide across 43,000 claims for 11,000 beneficiaries.
How many Methazolamide products are on the market?
The Methazolamide drug market contains 12 NDCs from 6 manufacturers — 12 generic and 0 brand products.
What is the price range for Methazolamide?
NADAC reference prices for Methazolamide range from $0.6275 to $1.5082 per EA — the most expensive product costs about 2.4× the cheapest.
Which manufacturers make Methazolamide?
6 manufacturers list Methazolamide in NADAC. Ranked by number of NDCs, the largest are Oceanside Pharmaceuticals (2), Padagis US LLC (2), NorthStar Rx LLC (2), ANI Pharmaceuticals, Inc. (2), Precision Dose Inc. (2).
How has the price of Methazolamide changed recently?
Over the past 7 days, 0 Methazolamide NDCs rose and 9 fell, with a market-wide average change of -3.8%.